Structural chemistry of the histone methyltransferases cofactor binding site

Journal of Chemical Information and Modeling

Volumn 51, Issue 3, 2011, Pages 612-623

  Campagna Slater, Valérie ^a,d   Mok, Man Wai ^a   Nguyen, Kong T ^a   Feher, Miklos ^b   Najmanovich, Rafael ^c   Schapira, Matthieu ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF SHERBROOKE   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; PROTEINS; TRANSCRIPTION;

CHROMATIN COMPACTION; GENE TRANSCRIPTIONS; HISTONE METHYLTRANSFERASES; S-ADENOSYL METHIONINES; SELECTIVE INHIBITION; STRUCTURAL CHEMISTRY; SYSTEMATIC ANALYSIS; TARGET VALIDATIONS;

BINDING SITES;

HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; PHYLOGENY; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

BINDING SITES; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; MODELS, MOLECULAR; PHYLOGENY; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

EID: 79953187310     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci100479z     Document Type: Article

References (40)

1. Frye, S. V. Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era Chem. Biol. 1999, 6, R3-R7
2. Bredel, M.; Jacoby, E. Chemogenomics: an emerging strategy for rapid target and drug discovery Nat. Rev. Genet. 2004, 5, 262-275 (Pubitemid 38435622)
3. Jacoby, E.; Schuffenhauer, A.; Floersheim, P. Chemogenomics knowledge-based strategies in drug discovery Drug News Perspect. 2003, 16, 93-102 (Pubitemid 36749735)
4. Klabunde, T. Chemogenomic approaches to drug discovery: similar receptors bind similar ligands Br. J. Pharmacol. 2007, 152, 5-7 (Pubitemid 47339899)
5. Harris, C. J.; Stevens, A. P. Chemogenomics: structuring the drug discovery process to gene families Drug Discovery Today 2006, 11, 880-888 (Pubitemid 44403186)
6. Fernandez, A.; Sanguino, A.; Peng, Z.; Crespo, A.; Ozturk, E.; Zhang, X.; Wang, S.; Bornmann, W.; Lopez-Berestein, G. Rational drug redesign to overcome drug resistance in cancer therapy: imatinib moving target Cancer Res. 2007, 67, 4028-4033 (Pubitemid 46815047)
7. Karaman, M. W.; Herrgard, S.; Treiber, D. K.; Gallant, P.; Atteridge, C. E.; Campbell, B. T.; Chan, K. W.; Ciceri, P.; Davis, M. I.; Edeen, P. T.; Faraoni, R.; Floyd, M.; Hunt, J. P.; Lockhart, D. J.; Milanov, Z. V.; Morrison, M. J.; Pallares, G.; Patel, H. K.; Pritchard, S.; Wodicka, L. M.; Zarrinkar, P. P. A quantitative analysis of kinase inhibitor selectivity Nat. Biotechnol. 2008, 26, 127-132
8. Copeland, R. A.; Olhava, E. J.; Scott, M. P. Targeting epigenetic enzymes for drug discovery Curr. Opin. Chem. Biol. 2010, 14, 505-510
9. Xu, W. S.; Parmigiani, R. B.; Marks, P. A. Histone deacetylase inhibitors: molecular mechanisms of action Oncogene 2007, 26, 5541-5552 (Pubitemid 47255934)
10. Copeland, R. A.; Solomon, M. E.; Richon, V. M. Protein methyltransferases as a target class for drug discovery Nat. Rev. Drug Discovery 2009, 8, 724-732
11. Spannhoff, A.; Hauser, A. T.; Heinke, R.; Sippl, W.; Jung, M. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors ChemMedChem 2009, 4, 1568-1582
12. Zhang, Y.; Reinberg, D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails Genes Dev. 2001, 15, 2343-2360 (Pubitemid 32899739)
13. Kouzarides, T. Histone methylation in transcriptional control Curr. Opin. Genet. Dev. 2002, 12, 198-209 (Pubitemid 34219493)
14. Völkel, P.; Angrand, P.-O. The control of histone lysine methylation in epigenetic regulation Biochimie 2007, 89, 1-20 (Pubitemid 44970511)
15. Martin, C.; Zhang, Y. The diverse functions of histone lysine methylation Nat. Rev. Mol. Cell Bio. 2005, 6, 838-849 (Pubitemid 41568733)
16. Bedford, M. T.; Richard, S. Arginine Methylation: An Emerging Regulator of Protein Function Mol. Cell 2005, 18, 263-272 (Pubitemid 41350532)
17. Chang, Y.; Zhang, X.; Horton, J. R.; Upadhyay, A. K.; Spannhoff, A.; Liu, J.; Snyder, J. P.; Bedford, M. T.; Cheng, X. Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294 Nat. Struct. Mol. Biol. 2009, 16, 312-317
18. Liu, F.; Chen, X.; Allali-Hassani, A.; Quinn, A. M.; Wasney, G. A.; Dong, A.; Barsyte, D.; Kozieradzki, I.; Senisterra, G.; Chau, I.; Siarheyeva, A.; Kireev, D. B.; Jadhav, A.; Herold, J. M.; Frye, S. V.; Arrowsmith, C. H.; Brown, P. J.; Simeonov, A.; Vedadi, M.; Jin, J. Discovery of a 2,4-diamino-7- aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a J. Med. Chem. 2009, 52, 7950-7953
19. Liu, F.; Chen, X.; Allali-Hassani, A.; Quinn, A. M.; Wigle, T. J.; Wasney, G. A.; Dong, A.; Senisterra, G.; Chau, I.; Siarheyeva, A.; Norris, J. L.; Kireev, D. B.; Jadhav, A.; Herold, J. M.; Janzen, W. P.; Arrowsmith, C. H.; Frye, S. V.; Brown, P. J.; Simeonov, A.; Vedadi, M.; Jin, J. Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines J. Med. Chem. 2010, 53, 5844-5857
20. Greiner, D.; Bonaldi, T.; Eskeland, R.; Roemer, E.; Imhof, A. Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9 Nat. Chem. Biol. 2005, 1, 143-145
21. DeLano, W. L. Unraveling hot spots in binding interfaces: progress and challenges Curr. Opin. Struct. Biol. 2002, 12, 14-20
22. Qian, C.; Zhou, M. M. SET domain protein lysine methyltransferases: Structure, specificity and catalysis Cell. Mol. Life Sci. 2006, 63, 2755-2763 (Pubitemid 44913316)
23. Schultz, J.; Milpetz, F.; Bork, P.; Ponting, C. P. SMART, a simple modular architecture research tool: identification of signaling domains Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 5857-5864 (Pubitemid 28248931)
24. Krause, C. D.; Yang, Z. H.; Kim, Y. S.; Lee, J. H.; Cook, J. R.; Pestka, S. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential Pharmacol. Therapeut. 2007, 113, 50-87 (Pubitemid 46017068)
25. Feng, Q.; Wang, H.; Ng, H. H.; Erdjument-Bromage, H.; Tempst, P.; Struhl, K.; Zhang, Y. Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain Curr. Biol. 2002, 12, 1052-1058 (Pubitemid 34703339)
26. Halgren, T. A. Identifying and Characterizing Binding Sites and Assessing Druggability J. Chem. Inf. Model 2009, 49, 377-389
27. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules J. Med. Chem. 1985, 28, 849-857 (Pubitemid 15012490)
28. Boobbyer, D. N.; Goodford, P. J.; McWhinnie, P. M.; Wade, R. C. New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structure J. Med. Chem. 1989, 32, 1083-1094 (Pubitemid 19122160)
29. McConkey, B. J.; Sobolev, V.; Edelman, M. Quantification of protein surfaces, volumes and atom-atom contacts using a constrained Voronoi procedure Bioinformatics 2002, 18, 1365-1373 (Pubitemid 35244194)
30. Najmanovich, R.; Kurbatova, N.; Thornton, J. Detection of 3D atomic similarities and their use in the discrimination of small molecule protein-binding sites Bioinformatics 2008, 24, i105-i111
31. Schapira, M.; Totrov, M.; Abagyan, R. Prediction of the binding energy for small molecules, peptides and proteins J. Mol. Recognit. 1999, 12, 177-190 (Pubitemid 29266968)
32. Janin, J.; Chothia, C. Role of hydrophobicity in the binding of coenzymes. Appendix. Translational and rotational contribution to the free energy of dissociation Biochemistry 1978, 17, 2943-2948
33. Henrich, S.; Salo-Ahen, O. M.; Huang, B.; Rippmann, F. F.; Cruciani, G.; Wade, R. C. Computational approaches to identifying and characterizing protein binding sites for ligand design J. Mol. Recognit. 2010, 23, 209-219
34. Sheridan, R. P.; Maiorov, V. N.; Holloway, M. K.; Cornell, W. D.; Gao, Y. D. Drug-like density: a method of quantifying the "bindability" of a protein target based on a very large set of pockets and drug-like ligands from the Protein Data Bank J. Chem. Inf. Model. 2010, 50, 2029-2040
35. Fedorov, O.; Marsden, B.; Pogacic, V.; Rellos, P.; Muller, S.; Bullock, A. N.; Schwaller, J.; Sundstrom, M.; Knapp, S. A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 20523-20528
36. Martin, J. L.; McMillan, F. M. SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold Curr. Opin. Struct. Biol. 2002, 12, 783-793 (Pubitemid 36009496)
37. Sirinupong, N.; Brunzelle, J.; Ye, J.; Pirzada, A.; Nico, L.; Yang, Z. Crystal structure of cardiac specific histone methyltransferase SmyD1 reveals unusual active site architecture J. Biol. Chem. 2010, 285, 40635-40644
38. Dowden, J.; Hong, W.; Parry, R. V.; Pike, R. A.; Ward, S. G. Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases Bioorg. Med. Chem. Lett. 2010, 20, 2103-2105
39. Nolen, B.; Taylor, S.; Ghosh, G. Regulation of protein kinases; controlling activity through activation segment conformation Mol. Cell 2004, 15, 661-675 (Pubitemid 39194898)
40. Wu, H.; Min, J.; Lunin, V. V.; Antoshenko, T.; Dombrovski, L.; Zeng, H.; Allali-Hassani, A.; Campagna-Slater, V.; Vedadi, M.; Arrowsmith, C. H.; Plotnikov, A. N.; Schapira, M. Structural biology of human H3K9 methyltransferases PLoS One 2010, 5, e8570